CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Recruiting · NCT07441291 · Registry updated 2026-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT | Neoplasm, Residual, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 3 | 2026-02-27 | NCT07441291 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University People's Hospital | 269 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University People's Hospital | Beijing | China | 5 |